New Ways to Treat Challenging Diseases
Trillions of bacteria, viruses, and other microbes live in our bodies and work together to regulate processes critical to life including metabolism and the immune system. Collectively, the genetic material of these microbes forms the human microbiome.
The literal explosion of interest in the human microbiome has been sparked in part by the Human Microbiome Project, a 5-year effort sponsored by the US National Institutes of Health. The goal of the Human Microbiome Project was to characterize the microbial communities found at several different sites on the human body and to analyze the role of those microbes in human health and disease.
One of the focal points of the Human Microbiome Project was the human intestine. With its complex ecosystem and the most diverse microbes and the densest number of cells, the intestinal microbiome has continued to be a subject of intense research interest.
It is the goal of Rebiotix to harness the power of the microbiome to treat challenging gastrointestinal diseases by developing new biologic drugs.